| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/23/1999 | WO1999047162A1 Products in the treatment of cancer |
| 09/23/1999 | WO1999047153A2 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY rho GTPase FUNCTION INHIBITORS |
| 09/23/1999 | WO1999047151A1 Peptide ligands for the erythropoietin receptor |
| 09/23/1999 | WO1999047147A1 nrdG |
| 09/23/1999 | WO1999047146A1 Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor |
| 09/23/1999 | WO1999047143A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 09/23/1999 | WO1999047142A1 Combination of a gaba-a alpha 5 inverse agonist and a nicotinic agonist |
| 09/23/1999 | WO1999047138A1 Statin-matrix metalloproteinase inhibitor combinations |
| 09/23/1999 | WO1999047136A1 Prevention and treatment of adhesions |
| 09/23/1999 | WO1999047131A2 Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor |
| 09/23/1999 | WO1999047123A1 Pharmaceutical composition containing a statin and aspirin |
| 09/23/1999 | WO1999047119A1 Methods for regulating skin appearance |
| 09/23/1999 | WO1999047118A1 Compositions for regulating skin appearance |
| 09/23/1999 | WO1999041374A3 Human short-chain tnf-receptor family protein |
| 09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
| 09/23/1999 | WO1999039740A8 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 09/23/1999 | WO1999036570A3 Transglutaminase linkage of agents to tissue |
| 09/23/1999 | WO1999036100A3 Polymeric carrier |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | WO1999030727A9 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 09/23/1999 | WO1999017755A3 Medicaments |
| 09/23/1999 | WO1999012531A3 Hormonal contraceptive |
| 09/23/1999 | CA2324337A1 Products in the treatment of cancer |
| 09/23/1999 | CA2324237A1 Combination of a gaba-a alpha 5 inverse agonist and a nicotinic agonist |
| 09/23/1999 | CA2324138A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same |
| 09/23/1999 | CA2323830A1 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 09/23/1999 | CA2323784A1 Carrier for in vivo delivery of a therapeutic agent |
| 09/23/1999 | CA2323618A1 Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor |
| 09/23/1999 | CA2323364A1 Compositions for regulating skin appearance |
| 09/23/1999 | CA2323181A1 Methods for regulating skin appearance |
| 09/23/1999 | CA2309588A1 Statin-matrix metalloproteinase inhibitor combinations |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943333A1 Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis |
| 09/22/1999 | EP0943332A1 Prevention and treatment of adhesions |
| 09/22/1999 | EP0943328A2 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 09/22/1999 | EP0943311A2 Method of inhibiting hair growth |
| 09/22/1999 | EP0943008A1 Metal mediated serine protease inhibitors |
| 09/22/1999 | EP0942998A1 Notch |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/22/1999 | EP0942973A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 09/22/1999 | EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 09/22/1999 | EP0942960A1 Promotion of regeneration of organized tissues |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942931A2 Modulation of interactions between myosin and integrins |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942753A1 Combinations for use in increasing the potency of a substrate for multidrug resistance related protein |
| 09/22/1999 | EP0942752A1 Anticonvulsant containing composition for treating neuropathic pain |
| 09/22/1999 | EP0942751A1 Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter |
| 09/22/1999 | EP0942750A1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 09/22/1999 | EP0942746A1 Inhibition of invasive remodelling |
| 09/22/1999 | EP0942741A1 Lectin compositions and uses thereof |
| 09/22/1999 | EP0942740A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 09/22/1999 | EP0942739A1 Biomaterial derived from vertebrate liver tissue |
| 09/22/1999 | EP0942735A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders |
| 09/22/1999 | EP0942734A1 Use of nk-1 receptor antagonists for treating severe anxiety disorders |
| 09/22/1999 | EP0942733A1 Use of nk-1 receptor antagonists for treating cognitive disorders |
| 09/22/1999 | EP0942732A1 Use of nk-1 receptor antagonists for treating movement disorders |
| 09/22/1999 | EP0942731A1 Use of nk-1 receptor antagonists for treating substance use disorders |
| 09/22/1999 | EP0942730A1 Use of nk-1 receptor antagonists for treating bipolar disorders |
| 09/22/1999 | EP0942729A1 Use of nk-1 receptor antagonists for treating stress disorders |
| 09/22/1999 | EP0942728A1 Use of nk-1 receptor antagonists for treating sexual dysfunction |
| 09/22/1999 | EP0942721A1 Pharmaceutical composition |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | EP0517836B1 Method and product for promoting hair growth and treating skin conditions |
| 09/22/1999 | CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/22/1999 | CN1229359A Dendritic cell stimulatory factor |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1228962A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/22/1999 | CN1045160C Hair growth modification |
| 09/21/1999 | US5955624 Angiogenic isolated alk-1-enyl glycerol derivative |
| 09/21/1999 | US5955594 Nucleic acids encoding proteins for early liver development |
| 09/21/1999 | US5955504 Administering enantiomerically stable antiinflammatory agents/non-steroids/ or a pharmaceutically acceptable salts to treat colon cancer |
| 09/21/1999 | US5955485 2,3-dihydro-imidazo(2,1-b)benzothiazole derivatives |
| 09/21/1999 | US5955474 Antiedema agents or diuretic antagonist |
| 09/21/1999 | US5955451 Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
| 09/21/1999 | US5955429 Human apoptosis-associated protein |
| 09/21/1999 | US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 09/21/1999 | US5955337 Lyase enzyme which can be used to screen fungicidal compounds |
| 09/21/1999 | US5955314 Nucleotide sequence that codes polypeptide controller of g-protein signaling; prevention and diagnosis of cancer; anticarcinogenic agents; antiinflammatory agents; therapy of nervous system disorders; antisense agents |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955303 Human chemokine receptor-like protein |
| 09/21/1999 | US5955299 For diagnosis and treatment of systemic lupus erythematosus; antisense agents |
| 09/21/1999 | US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases |
| 09/21/1999 | US5955282 Human galactosyltransferases |
| 09/21/1999 | US5955278 Polynucleotide sequences coding human protein synthesis controller; useful in diagnosis, prevention, and therapy for apoptosis; antiinflammatory agents; anticarcinogenic agents; antiproliferative agents |
| 09/21/1999 | US5955103 Dosage form comprising antiepileptic drug |
| 09/21/1999 | US5955100 Prodrugs their preparation and use as pharmaceuticals |
| 09/16/1999 | WO1999046390A1 Chitinase chitin-binding fragments |
| 09/16/1999 | WO1999046379A2 Human receptor proteins; related reagents and methods |
| 09/16/1999 | WO1999046284A2 Molecules that home to various selected organs or tissues |
| 09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 09/16/1999 | WO1999046277A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 09/16/1999 | WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS) |
| 09/16/1999 | WO1999045974A1 Protease inhibitors in absorbent articles |
| 09/16/1999 | WO1999045973A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 09/16/1999 | WO1999045970A1 Multicomponent complex for use with a substrate |